Acorda Therapeutics, Inc.
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders.
Find locations served, office locations
- Business Type:
- Industry Type:
- Market Focus:
- Nationally (across the country)
- Year Founded:
Millions of people with nervous system disorders are in need of new therapeutic options. We never forget that these people may include our own family members or friends, and that these are not just diseases to be treated, but people who need help to make their lives, and those of their loved ones, better.
In this section, you’ll meet some of the people at Acorda are taking new approaches to developing medications that provide hope for people with nervous system disorders – and go beyond the walls of the company to improve lives. You’ll also find out how our partnerships and grant program are advancing research and education, and the process for submitting grant requests.
Acorda’s mission is to develop therapies that restore function and improve the lives of people with neurological disorders.
Message from Biotechnology Innovation Organization (BIO)
WHAT IS BIOTECHNOLOGY?
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.
Modern biotechnology provides breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes.
Currently, there are more than 250 biotechnology health care products and vaccines available to patients, many for previously untreatable diseases. More than 13.3 million farmers around the world use agricultural biotechnology to increase yields, prevent damage from insects and pests and reduce farming’s impact on the environment. And more than 50 biorefineries are being built across North America to test and refine technologies to produce biofuels and chemicals from renewable biomass, which can help reduce greenhouse gas emissions.
In this section, we will provide periodic updates on key issues facing the advancement of science and the ability of researcher and entrepreneurs to deliver the latest medical and biological breakthroughs to people who need them around the world.
Ensuring that our families and loved ones have access to the medicines and treatments they need is one of the most important issues we face as individuals and as a society. Yet, understanding the complexities and various entities that make up our nation’s health care system can be a daunting and extremely frustrating endeavor.
To make it a bit easier, there is a new interactive tool called drugcostfacts.org
The site features a series of commonly asked questions—ranging from “Why are some drugs expensive?” to “What role do PBMs, insurance companies and wholesalers play in determining what patients pay for their drugs?”—and then answers these questions using infographics, videos and interactive tools. The site also has additional research and reading materials if you want to dive deeper into these issues. The tool is mobile responsive, allowing you to access information on your phone or tablet.
Drugcostfacts.org also features a “Follow the Debate” section, where you can get more information on topics ranging from drug importation to government negotiations in Medicare that are making headlines and that are part of the current policy and public debate.
The goal of the site is to be a one-stop shop for information and answers to some of the most hotly debated questions regarding the role of prescription drugs in our nation’s health care system.
BECOME AN ADVOCATE FOR BIOTECHNOLOGY…JOIN BIOACTION
As breakthroughs in science and medicine transform the way we treat patients for a wide range of diseases and ailments, it is critical that we educate and inform public policy makers and elected officials about how their actions can impact medical advancements and the development of new medicines. Make your voice heard! It’s easy to do – check out BIO’s new online tool to contact your federal or state public officials with your views via e-mail, phone or social media. The site also features background and information on key issues impacting the development of new medicines and patient access to the medicines they need. Go ahead and try it out!
Diversity and Inclusion
Our goal is to be the leading biopharmaceutical company developing and marketing therapies that restore function and improve the lives of people with neurological disorders.
We believe that an important contributor to our success is that we value the diversity of talents, backgrounds, perspectives, and intellectual approaches that our associate brings to our organization. These differences enrich our conversations and challenge us to think differently. In so doing, they also allow us to understand and more effectively address needs across the wide diversity of our patient, scientific and medical communities.
We have adopted the Biotechnology Innovation Organization’s principles on workforce development, diversity and inclusion: www.bio.org/diversity.
- We believe that diversity in all aspects of business operations will optimize the continued growth and success of our company and the biotechnology industry.
- We will lead by example in our diversity efforts and will incorporate diversity and inclusion into all aspects of our operations.
- We will champion workforce development, diversity and inclusion as a way to attract, develop and retain our talent pool within the globally competitive biotechnology industry.
- We will engage with external partners to broaden the reach and incorporation of diversity throughout the biotechnology ecosystem.
- We believe our technologies and products should address the needs of a diverse population.
We’ve been recognized as one of the nation’s “Best Workplaces for Women” by Fortune in 2015 and 2016 and “Best Workplaces for Baby Boomers” by Fortune in 2016.